Rui Ping Xiao
Founder chez Hope Medicine (Nanjing) Co., Ltd.
Profil
Rui Ping Xiao founded Hope Medicine (Nanjing) Co., Ltd.
in 2018, where she is working as Chairman from 2021.
Dr. Xiao also founded The Institute of Molecular Medicine, where she worked as Director.
Dr. Xiao also currently works at Peking University, as Dean from 2020, International Society For Heart Research, as Council Member from 2002, and Vivere Lifesciences Acquisition Corp., as Advisor.
Dr. Xiao received her graduate degree in 1995 from the University of Maryland School of Medicine and undergraduate degree in 1984 and graduate degree in 1987 from Tongji Medical College of Huazhong University of Sci & Tech.
Postes actifs de Rui Ping Xiao
| Sociétés | Poste | Début |
|---|---|---|
Vivere Lifesciences Acquisition Corp.
 Vivere Lifesciences Acquisition Corp. Financial ConglomeratesFinance Vivere Lifesciences Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Siu Wai Ng, Jie Lun Zhu and Ya Chun Chen on February 8, 2022 and is headquartered in Hong Kong. | Corporate Officer/Principal | - |
Peking University
 Peking University Other Consumer ServicesConsumer Services Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China. | Corporate Officer/Principal | 01/09/2020 |
| International Society For Heart Research | Corporate Officer/Principal | 01/01/2002 |
Hope Medicine (Nanjing) Co., Ltd.
 Hope Medicine (Nanjing) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Hope Medicine (HK) Ltd., Hope Medicine (Nanjing) Co., Ltd. is a pharmaceutical company based in Shanghai, China. The Chinese company manufactures pharmaceutical products. The private company was founded in 2018 by Shi Lou, Rui Ping Xiao. Henri Nico Doods has been the CEO of the company since 2020. | Founder | 01/01/2018 |
Anciens postes connus de Rui Ping Xiao
| Sociétés | Poste | Fin |
|---|---|---|
| The Institute of Molecular Medicine | Founder | - |
Formation de Rui Ping Xiao
| University of Maryland School of Medicine | Graduate Degree |
| Tongji Medical College of Huazhong University of Sci & Tech | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
| The Institute of Molecular Medicine | |
Hope Medicine (Nanjing) Co., Ltd.
Hope Medicine (Nanjing) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Hope Medicine (HK) Ltd., Hope Medicine (Nanjing) Co., Ltd. is a pharmaceutical company based in Shanghai, China. The Chinese company manufactures pharmaceutical products. The private company was founded in 2018 by Shi Lou, Rui Ping Xiao. Henri Nico Doods has been the CEO of the company since 2020. | Health Technology |
| International Society For Heart Research | |
Vivere Lifesciences Acquisition Corp.
Vivere Lifesciences Acquisition Corp. Financial ConglomeratesFinance Vivere Lifesciences Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Siu Wai Ng, Jie Lun Zhu and Ya Chun Chen on February 8, 2022 and is headquartered in Hong Kong. | Finance |
